CAY10731（Cat No.:I043815）is a selective inhibitor of the enzyme 5-lipoxygenase (5-LOX), which plays a crucial role in the biosynthesis of leukotrienes, inflammatory mediators involved in allergic reactions, asthma, and other inflammatory diseases. By inhibiting 5-LOX, CAY10731 reduces the production of leukotrienes, thus decreasing inflammation and allergic responses. This compound holds potential for the treatment of conditions like asthma, chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease (IBD). CAY10731’s ability to target specific pathways involved in inflammation makes it a promising candidate for managing chronic inflammatory disorders.